Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva introduces infant formula in Israel
The infant formula is available in 400gm and 800gm cans, globes.co.il reported. The company is said to have invested a large amount in the launch and expects to
The infant formula is available in 400gm and 800gm cans, globes.co.il reported. The company is said to have invested a large amount in the launch and expects to
Oxycodone is a narcotic pain-reliever and cough suppressant similar to morphine, codeine, and hydrocodone. The drug does not eliminate the sensation of pain but provides comfort by increasing
The company claimed that the body has a specific gene to produce an ergothioneine transporter. It also claimed that the L-ergothioneine has shown specific promise in extending healthy
FlexTouch, an insulin injection containing 300 units of insulin features a spring which enables administration of insulin at any dose (from 1 to 80 units) with a touch
BIT225, an orally administered, small molecule drug demonstrated good antiviral activity against HCV. The drug specifically targets the p7 protein, a viral protein essential to virus production and
The drugs include LNA tm as the active pharmaceutical ingredient. The new products include oxy-LNA tm amidites in kilogram quantities, LNA tm oligonucleotides in gram quantities, miRCURY LNA
The FDA has proposed design of Phase 3 studies and the development program in support of a New Drug Application (NDA) for VivaGel to treat BV. The two
Paladin Labs is focused on in-licensing pharmaceutical products for the Canadian and world markets. Paladin Labs interim president and CEO Mark Beaudet said the acquisition of Labopharm will
Olanzapine, a generic version of Zyprexa (Olanzapine) from Eli Lilly is used to treat schizophrenia. The drug helps in manic episode treatment and prevents its recurrence in patients
The net income denotes $0.05 per diluted common share, compared with a loss of $2.1m or $0.19 per common share for the quarter. The company posted loss from